Global Oncology Biosimilars Market Insights, Forecast to 2025

Global Oncology Biosimilars Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Oncology Biosimilars Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oncology Biosimilars Market Size Growth Rate by Product
1.4.2 mAb
1.4.3 Immunomodulators
1.4.4 Hematopoietic Agents
1.4.5 G-CSF 
1.4.6 Others
1.5 Market by End User
1.5.1 Global Oncology Biosimilars Market Size Growth Rate by End User
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oncology Biosimilars Market Size
2.1.1 Global Oncology Biosimilars Revenue 2014-2025
2.1.2 Global Oncology Biosimilars Sales 2014-2025
2.2 Oncology Biosimilars Growth Rate by Regions
2.2.1 Global Oncology Biosimilars Sales by Regions
2.2.2 Global Oncology Biosimilars Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Oncology Biosimilars Sales by Manufacturers
3.1.1 Oncology Biosimilars Sales by Manufacturers
3.1.2 Oncology Biosimilars Sales Market Share by Manufacturers
3.1.3 Global Oncology Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Oncology Biosimilars Revenue by Manufacturers
3.2.1 Oncology Biosimilars Revenue by Manufacturers (2014-2019)
3.2.2 Oncology Biosimilars Revenue Share by Manufacturers (2014-2019)
3.3 Oncology Biosimilars Price by Manufacturers
3.4 Oncology Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Oncology Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Oncology Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Oncology Biosimilars Sales by Product
4.2 Global Oncology Biosimilars Revenue by Product
4.3 Oncology Biosimilars Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Oncology Biosimilars Breakdown Data by End User
6 North America
6.1 North America Oncology Biosimilars by Countries
6.1.1 North America Oncology Biosimilars Sales by Countries
6.1.2 North America Oncology Biosimilars Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Oncology Biosimilars by Product
6.3 North America Oncology Biosimilars by End User
7 Europe
7.1 Europe Oncology Biosimilars by Countries
7.1.1 Europe Oncology Biosimilars Sales by Countries
7.1.2 Europe Oncology Biosimilars Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oncology Biosimilars by Product
7.3 Europe Oncology Biosimilars by End User
8 Asia Pacific
8.1 Asia Pacific Oncology Biosimilars by Countries
8.1.1 Asia Pacific Oncology Biosimilars Sales by Countries
8.1.2 Asia Pacific Oncology Biosimilars Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Oncology Biosimilars by Product
8.3 Asia Pacific Oncology Biosimilars by End User
9 Central & South America
9.1 Central & South America Oncology Biosimilars by Countries
9.1.1 Central & South America Oncology Biosimilars Sales by Countries
9.1.2 Central & South America Oncology Biosimilars Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Oncology Biosimilars by Product
9.3 Central & South America Oncology Biosimilars by End User
10 Middle East and Africa
10.1 Middle East and Africa Oncology Biosimilars by Countries
10.1.1 Middle East and Africa Oncology Biosimilars Sales by Countries
10.1.2 Middle East and Africa Oncology Biosimilars Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Oncology Biosimilars by Product
10.3 Middle East and Africa Oncology Biosimilars by End User
11 Company Profiles
11.1 Celltrion
11.1.1 Celltrion Company Details
11.1.2 Company Business Overview
11.1.3 Celltrion Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Celltrion Oncology Biosimilars Products Offered
11.1.5 Celltrion Recent Development
11.2 Biocon
11.2.1 Biocon Company Details
11.2.2 Company Business Overview
11.2.3 Biocon Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Biocon Oncology Biosimilars Products Offered
11.2.5 Biocon Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Details
11.3.2 Company Business Overview
11.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Dr. Reddy's Laboratories Oncology Biosimilars Products Offered
11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 STADA Arzneimittel AG
11.4.1 STADA Arzneimittel AG Company Details
11.4.2 Company Business Overview
11.4.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.4.4 STADA Arzneimittel AG Oncology Biosimilars Products Offered
11.4.5 STADA Arzneimittel AG Recent Development
11.5 Intas Pharmaceuticals
11.5.1 Intas Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Intas Pharmaceuticals Oncology Biosimilars Products Offered
11.5.5 Intas Pharmaceuticals Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Business Overview
11.6.3 Pfizer Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Pfizer Oncology Biosimilars Products Offered
11.6.5 Pfizer Recent Development
11.7 Sandoz International
11.7.1 Sandoz International Company Details
11.7.2 Company Business Overview
11.7.3 Sandoz International Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sandoz International Oncology Biosimilars Products Offered
11.7.5 Sandoz International Recent Development
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Teva Pharmaceutical Industries Ltd Company Details
11.8.2 Company Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Products Offered
11.8.5 Teva Pharmaceutical Industries Ltd Recent Development
11.9 Apotex
11.9.1 Apotex Company Details
11.9.2 Company Business Overview
11.9.3 Apotex Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Apotex Oncology Biosimilars Products Offered
11.9.5 Apotex Recent Development
11.10 BIOCAD
11.10.1 BIOCAD Company Details
11.10.2 Company Business Overview
11.10.3 BIOCAD Oncology Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.10.4 BIOCAD Oncology Biosimilars Products Offered
11.10.5 BIOCAD Recent Development
12 Future Forecast
12.1 Oncology Biosimilars Market Forecast by Regions
12.1.1 Global Oncology Biosimilars Sales Forecast by Regions 2019-2025
12.1.2 Global Oncology Biosimilars Revenue Forecast by Regions 2019-2025
12.2 Oncology Biosimilars Market Forecast by Product
12.2.1 Global Oncology Biosimilars Sales Forecast by Product 2019-2025
12.2.2 Global Oncology Biosimilars Revenue Forecast by Product 2019-2025
12.3 Oncology Biosimilars Market Forecast by End User
12.4 North America Oncology Biosimilars Forecast
12.5 Europe Oncology Biosimilars Forecast
12.6 Asia Pacific Oncology Biosimilars Forecast
12.7 Central & South America Oncology Biosimilars Forecast
12.8 Middle East and Africa Oncology Biosimilars Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oncology Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Oncology Biosimilars Product Picture
Table Oncology Biosimilars Market Segments
Table Key Manufacturers Oncology Biosimilars Covered
Table Global Oncology Biosimilars Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Oncology Biosimilars Sales Market Share by Product 2014-2025
Figure mAb Product Picture
Table Major Manufacturers of mAb
Figure Immunomodulators Product Picture
Table Major Manufacturers of Immunomodulators
Figure Hematopoietic Agents Product Picture
Table Major Manufacturers of Hematopoietic Agents
Figure G-CSF  Product Picture
Table Major Manufacturers of G-CSF 
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Oncology Biosimilars Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Retail Pharmacies
Figure Hospital Pharmacy
Figure Online Pharmacy
Figure Oncology Biosimilars Report Years Considered
Figure Global Oncology Biosimilars Market Size 2014-2025 (Million US$)
Figure Global Oncology Biosimilars Sales 2014-2025 (K Units)
Table Global Oncology Biosimilars Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Oncology Biosimilars Sales by Regions 2014-2019 (K Units)
Table Global Oncology Biosimilars Sales Market Share by Regions 2014-2019
Figure Global Oncology Biosimilars Sales Market Share by Regions 2014-2019
Figure 2018 Global Oncology Biosimilars Sales Market Share by Regions
Table Global Oncology Biosimilars Revenue by Regions 2014-2019 (Million US$)
Table Global Oncology Biosimilars Revenue Market Share by Regions 2014-2019
Figure Global Oncology Biosimilars Revenue Market Share by Regions 2014-2019
Figure 2018 Global Oncology Biosimilars Revenue Market Share by Regions
Table Global Oncology Biosimilars Sales by Manufacturers (2014-2019) (K Units)
Table Global Oncology Biosimilars Sales Share by Manufacturers (2014-2019)
Figure Global Oncology Biosimilars Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Oncology Biosimilars Revenue by Manufacturers (2014-2019) (Million USD)
Table Oncology Biosimilars Revenue Share by Manufacturers (2014-2019)
Figure Oncology Biosimilars Value Share by Manufacturers in 2018
Table Key Manufacturers Oncology Biosimilars Price (2014-2019) (USD/Unit)
Table Oncology Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Oncology Biosimilars Product Type
Table Date of International Manufacturers Enter into Oncology Biosimilars Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Oncology Biosimilars Sales by Product (2014-2019) (K Units)
Table Global Oncology Biosimilars Sales Share by Product (2014-2019)
Figure Global Oncology Biosimilars Sales Market Share by Product (2014-2019)
Figure Global Oncology Biosimilars Sales Market Share by Product in 2018
Table Global Oncology Biosimilars Revenue by Product (2014-2019) (Million US$)
Table Global Oncology Biosimilars Revenue Share by Product (2014-2019)
Figure Global Oncology Biosimilars Revenue Market Share by Product (2014-2019)
Figure Global Oncology Biosimilars Revenue Market Share by Product in 2018
Table Oncology Biosimilars Price by Product 2014-2019 (USD/Unit)
Table Global Oncology Biosimilars Sales by End User (2014-2019) (K Units)
Table Global Oncology Biosimilars Sales Share by End User (2014-2019)
Figure Global Sales Oncology Biosimilars Market Share by End User (2014-2019)
Figure Global Sales Oncology Biosimilars Market Share by End User in 2018
Figure North America Oncology Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure North America Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table North America Oncology Biosimilars Sales by Countries (2014-2019) (K Units)
Table North America Oncology Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 North America Oncology Biosimilars Sales Market Share by Countries
Table North America Oncology Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table North America Oncology Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Oncology Biosimilars Revenue Market Share by Countries
Figure United States Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure United States Oncology Biosimilars Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Canada Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table North America Oncology Biosimilars Sales by Product (2014-2019) (K Units)
Table North America Oncology Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 North America Oncology Biosimilars Market Share by Product
Table North America Oncology Biosimilars Sales by End User (2014-2019) (K Units)
Table North America Oncology Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 North America Oncology Biosimilars Market Share by End User
Figure Europe Oncology Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Europe Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Oncology Biosimilars Sales by Countries (2014-2019) (K Units)
Table Europe Oncology Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Oncology Biosimilars Sales Market Share by Countries
Table Europe Oncology Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Europe Oncology Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Oncology Biosimilars Revenue Market Share by Countries
Figure Germany Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Germany Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure France Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure France Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure UK Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Italy Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Russia Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Oncology Biosimilars Sales by Product (2014-2019) (K Units)
Table Europe Oncology Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Europe Oncology Biosimilars Market Share by Product
Table Europe Oncology Biosimilars Sales by End User (2014-2019) (K Units)
Table Europe Oncology Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Europe Oncology Biosimilars Market Share by End User
Figure Asia Pacific Oncology Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Oncology Biosimilars Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Oncology Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Oncology Biosimilars Sales Market Share by Countries
Table Asia Pacific Oncology Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Oncology Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Oncology Biosimilars Revenue Market Share by Countries
Figure China Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure China Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Japan Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Korea Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure India Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure India Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Australia Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Oncology Biosimilars Sales by Product (2014-2019) (K Units)
Table Asia Pacific Oncology Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Oncology Biosimilars Market Share by Product
Table Asia Pacific Oncology Biosimilars Sales by End User (2014-2019) (K Units)
Table Asia Pacific Oncology Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Oncology Biosimilars Market Share by End User
Figure Central & South America Oncology Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Oncology Biosimilars Sales by Countries (2014-2019) (K Units)
Table Central & South America Oncology Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Oncology Biosimilars Sales Market Share by Countries
Table Central & South America Oncology Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Oncology Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Oncology Biosimilars Revenue Market Share by Countries
Figure Brazil Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Oncology Biosimilars Sales by Product (2014-2019) (K Units)
Table Central & South America Oncology Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Oncology Biosimilars Market Share by Product
Table Central & South America Oncology Biosimilars Sales by End User (2014-2019) (K Units)
Table Central & South America Oncology Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Oncology Biosimilars Market Share by End User
Figure Middle East and Africa Oncology Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Oncology Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Oncology Biosimilars Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Oncology Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Oncology Biosimilars Sales Market Share by Countries
Table Middle East and Africa Oncology Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries
Figure GCC Countries Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Oncology Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Oncology Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Oncology Biosimilars Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Oncology Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Oncology Biosimilars Market Share by Product
Table Middle East and Africa Oncology Biosimilars Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Oncology Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Oncology Biosimilars Market Share by End User
Table Celltrion Company Details
Table Celltrion Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Recent Development
Table Biocon Company Details
Table Biocon Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr. Reddy's Laboratories Recent Development
Table STADA Arzneimittel AG Company Details
Table STADA Arzneimittel AG Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table STADA Arzneimittel AG Recent Development
Table Intas Pharmaceuticals Company Details
Table Intas Pharmaceuticals Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Intas Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sandoz International Company Details
Table Sandoz International Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sandoz International Recent Development
Table Teva Pharmaceutical Industries Ltd Company Details
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd Recent Development
Table Apotex Company Details
Table Apotex Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Apotex Recent Development
Table BIOCAD Company Details
Table BIOCAD Oncology Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BIOCAD Recent Development
Table Global Oncology Biosimilars Sales Forecast by Regions 2019-2025 (K Units)
Table Global Oncology Biosimilars Sales Market Share Forecast by Regions 2019-2025
Table Global Oncology Biosimilars Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Oncology Biosimilars Revenue Market Share Forecast by Regions 2019-2025
Table Global Oncology Biosimilars Sales Forecast by Product 2019-2025 (K Units)
Table Global Oncology Biosimilars Sales Market Share Forecast by Product 2019-2025
Table Global Oncology Biosimilars Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Oncology Biosimilars Revenue Market Share Forecast by Product 2019-2025
Table Global Oncology Biosimilars Sales Forecast by End User 2019-2025 (K Units)
Table Global Oncology Biosimilars Sales Market Share Forecast by End User 2019-2025
Figure North America Oncology Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Oncology Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Oncology Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Oncology Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Oncology Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Oncology Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Oncology Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Oncology Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Oncology Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Oncology Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Oncology Biosimilars Value Chain
Table Oncology Biosimilars Customers List
Table Oncology Biosimilars Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs